Collegium Pharmaceutical Inc (COLL)

05:09 AM

Loomis Sayles & Co. L P Has $737,000 Holdings in Collegium Pharmaceutical, Inc. (NASDAQ:COLL) - MarketBeat

05:09 AM

04:37 AM

Penserra Capital Management LLC Invests $757,000 in Collegium Pharmaceutical, Inc. (NASDAQ:COLL) - MarketBeat

04:37 AM

Nov 27, 2024

Rubric Capital Management LP Lowers Stock Position in Collegium Pharmaceutical, Inc. (NASDAQ:COLL) - MarketBeat

Nov 27, 2024

Nov 27, 2024

Brokerages Set Collegium Pharmaceutical, Inc. (NASDAQ:COLL) Target Price at $42.60 - Defense World

Nov 27, 2024

Nov 26, 2024

Collegium Pharmaceutical: Strong Growth With Pain Management And ADHD Expansion - Seeking Alpha

Nov 26, 2024

Nov 26, 2024

Massachusetts Financial Services Co. MA Increases Stock Holdings in Collegium Pharmaceutical, Inc. (NASDAQ:COLL) - MarketBeat

Nov 26, 2024

Nov 24, 2024

Collegium Pharmaceutical, Inc. (NASDAQ:COLL) Receives Average Recommendation of "Moderate Buy" from Brokerages - MarketBeat

Nov 24, 2024

Nov 22, 2024

Pacer Advisors Inc. Sells 818,721 Shares of Collegium Pharmaceutical, Inc. (NASDAQ:COLL) - MarketBeat

Nov 22, 2024

Nov 20, 2024

Is the Options Market Predicting a Spike in Collegium Pharmaceutical (COLL) Stock? - MSN

Nov 20, 2024

Nov 18, 2024

Amalgamated Bank Has $372,000 Holdings in Collegium Pharmaceutical, Inc. (NASDAQ:COLL) - Defense World

Nov 18, 2024

Nov 18, 2024

121,446 Shares in Collegium Pharmaceutical, Inc. (NASDAQ:COLL) Acquired by Empowered Funds LLC - MarketBeat

Nov 18, 2024

Nov 18, 2024

Victory Capital Management Inc. Purchases 215,874 Shares of Collegium Pharmaceutical, Inc. (NASDAQ:COLL) - MarketBeat

Nov 18, 2024

Nov 14, 2024

Shareholders Can Be Confident That Collegium Pharmaceutical's (NASDAQ:COLL) Earnings Are High Quality - Simply Wall St

Nov 14, 2024

Nov 14, 2024

Collegium Pharmaceutical's (NASDAQ:COLL) Performance Is Even Better Than Its Earnings Suggest - Yahoo Finance

Nov 14, 2024

Nov 14, 2024

Rubric Capital Management LP Adjusts Stake in Collegium Pharmace - GuruFocus.com

Nov 14, 2024

Nov 13, 2024

Is Collegium Pharmaceutical (COLL) a Great Value Stock Right Now? - MSN

Nov 13, 2024

Nov 12, 2024

Collegium Pharmaceutical Inc (COLL) Stock Price Down 3.67% on No - GuruFocus.com

Nov 12, 2024

Nov 12, 2024

Collegium to Participate in Upcoming Investor Conferences - GlobeNewswire

Nov 12, 2024

Nov 12, 2024

Collegium Pharmaceutical to Present at Major Healthcare Investor Conferences | COLL Stock News - StockTitan

Nov 12, 2024

Nov 11, 2024

Meritage Portfolio Management Purchases New Stake in Collegium Pharmaceutical, Inc. (NASDAQ:COLL) - MarketBeat

Nov 11, 2024

Nov 11, 2024

New York State Teachers Retirement System Lowers Position in Collegium Pharmaceutical, Inc. (NASDAQ:COLL) - Defense World

Nov 11, 2024

Nov 10, 2024

Principal Financial Group Inc. Has $67.46 Million Stock Holdings in Collegium Pharmaceutical, Inc. (NASDAQ:COLL) - MarketBeat

Nov 10, 2024

Nov 09, 2024

Collegium Pharmaceutical, Inc. (NASDAQ:COLL) Q3 2024 Earnings Call Transcript - Insider Monkey

Nov 09, 2024

Nov 09, 2024

Collegium Pharmaceutical Third Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags - Yahoo Finance

Nov 09, 2024

Nov 09, 2024

Collegium Pharmaceutical Inc (COLL) Q3 2024 Earnings Call Highlights: Record Revenue Growth and ... By GuruFocus - Investing.com Canada

Nov 09, 2024

Nov 09, 2024

Collegium Pharmaceutical, Inc. (NASDAQ:COLL) Shares Bought by Robeco Institutional Asset Management B.V. - MarketBeat

Nov 09, 2024

Nov 08, 2024

Collegium appoints new CEO Vikram Karnani By Investing.com - Investing.com Australia

Nov 08, 2024

Nov 08, 2024

Collegium Pharmaceutical (COLL) Q3 Earnings and Revenues Lag Estimates - MSN

Nov 08, 2024

Nov 08, 2024

Here's What Key Metrics Tell Us About Collegium Pharmaceutical (COLL) Q3 Earnings - MSN

Nov 08, 2024

Nov 08, 2024

Collegium Pharmaceutical: Q3 Earnings Snapshot - The Washington Post

Nov 08, 2024

Nov 08, 2024

Collegium Pharmaceutical Reports Strong Q3 2024 Results - TipRanks

Nov 08, 2024

Nov 07, 2024

Collegium Pharmaceutical, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com

Nov 07, 2024

Nov 07, 2024

Collegium Pharmaceutical Taps Vikram Karnani as CEO - MarketWatch

Nov 07, 2024

Nov 07, 2024

Collegium Pharmaceutical earnings beat by $0.04, revenue topped estimates - Investing.com UK

Nov 07, 2024

Nov 07, 2024

Collegium appoints new CEO Vikram Karnani - Investing.com

Nov 07, 2024

Nov 07, 2024

Collegium Reports Record Third Quarter 2024 Financial Results - GlobeNewswire

Nov 07, 2024

Nov 07, 2024

Collegium Appoints Vikram Karnani as Chief Executive Officer - GlobeNewswire

Nov 07, 2024

Nov 07, 2024

Collegium Pharma Names Growth Expert Karnani as CEO Amid Record Revenue Success | COLL Stock News - StockTitan

Nov 07, 2024

Nov 06, 2024

A Preview Of Collegium Pharmaceutical's Earnings - Benzinga

Nov 06, 2024

Nov 06, 2024

What To Expect From Collegium Pharmaceutical Inc (COLL) Q3 2024 Earnings - Yahoo Finance

Nov 06, 2024

Nov 04, 2024

Collegium Pharmaceutical is Now Oversold (COLL) - Nasdaq

Nov 04, 2024

Nov 03, 2024

Emerald Advisers LLC Acquires 177,129 Shares of Collegium Pharmaceutical, Inc. (NASDAQ:COLL) - MarketBeat

Nov 03, 2024

Nov 02, 2024

Collegium Pharmaceutical, Inc. (NASDAQ:COLL) Receives $42.60 Average Target Price from Analysts - Defense World

Nov 02, 2024

Oct 31, 2024

(COLL) Trading Report - Stock Traders Daily

Oct 31, 2024

Oct 31, 2024

Collegium Pharmaceutical (COLL) Earnings Expected to Grow: What to Know Ahead of Next Week's Release - Yahoo Finance

Oct 31, 2024

Oct 31, 2024

Collegium Pharmaceutical (COLL) Set to Announce Quarterly Earnings on Thursday - MarketBeat

Oct 31, 2024

Oct 30, 2024

Collegium Pharmaceutical, Inc. (NASDAQ:COLL) Receives Consensus Rating of "Moderate Buy" from Brokerages - MarketBeat

Oct 30, 2024

Oct 30, 2024

Allspring Global Investments Holdings LLC Has $3.08 Million Holdings in Collegium Pharmaceutical, Inc. (NASDAQ:COLL) - MarketBeat

Oct 30, 2024

Oct 29, 2024

Assenagon Asset Management S.A. Sells 188,423 Shares of Collegium Pharmaceutical, Inc. (NASDAQ:COLL) - MarketBeat

Oct 29, 2024

Oct 29, 2024

Should Value Investors Buy Collegium Pharmaceutical (COLL) Stock? - MSN

Oct 29, 2024